S&P 500 index data: S&P 500 Copyright ©
|New Studies Investigating the Use of KEYTRUDA® (pembrolizumab), Merck’s Anti-PD-1 Therapy, in Advanced Melanoma Compared to Chemotherapy, in Classical Hodgkin Lymphoma and in Triple Negative Breast Cancer, to be Presented for the First Time|
|Global Diversified Investment Grade Income Trust II - Credit Event Notices (2014/11/21)|
|Data Investigating KEYTRUDA® (pembrolizumab), Merck’s Anti-PD-1 Therapy, in Patients with Classical Hodgkin Lymphoma Presented at ASH Annual Meeting|
|Canada's Favourite Coffee Celebrates Canada's Favourite Game (2014/10/8)|
|Cutwater Select Income Fund Declares Quarterly Dividend and Announces Results of Special Meeting of Shareholders|
|Managed Duration Investment Grade Municipal Fund Announces Results of Special Meeting of Shareholders|
Click above to view more mutual fund data and stats for 532992 - CHL Ltd.